Abstract
Objective To evaluate novel coronavirus pneumonia cases by establishing the mathematical model of the number of confirmed cases daily, and to assess the current situation and development of the epidemic situation, so as to provide a digital basis for decision-making.
Methods The number of newly confirmed covid-19 cases per day was taken as the research object, and the seven-day average value (M) and the sequential value (R) of M were calculated to study the occurrence and development of covid-19 epidemic through the analysis of charts and data.
Results M reflected the current situation of epidemic development; R reflected the current level of infection and the trend of epidemic development.
Conclusion The current data can be used to evaluate the number of people who have been infected, and when R < 1, the peak of epidemic can be predicted.
Preface In December 2019, a number of cases of pneumonia with unknown causes were found in some hospitals in Wuhan, Hubei province, China. On 11 March 2020, the director-general of the world health organization (WHO), Tedros Adhanom Ghebreyesus, announced that based on the assessment, WHO believes that the current outbreak of COVID-19 can be called a global pandemic. By early April 2020, there were more than one million confirmed cases worldwide.
COVID-19 has developed from sporadic cases to pandemic in a short period of 3 months. The analysis and research of its infectious data will help to prevent and control the next stage of epidemic prevention and other infectious diseases in the future.
In this paper, COVID-19 rounded average of seven days (M), and M’s ring ratio (R) are used to predict the current potential patients’ data, and the relative state of epidemic prevention and control is judged through the graphic features and characteristic data, so as to provide evidence for the prevention and control decisions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Reference: [1] Author: Health Emergency Office of the state health and Health Commission of the people's Republic of China Title: novel coronavirus pneumonia epidemic situation Published on the official website of the national health and Health Commission Year of publication: 2020 [2] By World Health Organization Title: situation report coronavirus disease 2019 (covid-19) Published on the official website of the World Health Organization Year of publication: 2020 [3] Author: Li Baojin; Wu Zilin; Hu Boyong; Chen Hongtao; Liao Silan; Ma CanYe; Liang Huichao; Title: novel coronavirus infection patients suspected and confirmed by surgical management guidelines Place of publication: Guangdong medicine (priority) Published on: February 28, 2020 [4] Data sources: WHO, CDC, ECDC, NHC, DXY, 1point3acres, Worldometers.info, BNO, state and national government health departments, and local media reports, the Johns Hopkins Coronavirus Resource Center .
